Independent Research Projects
Dragonfly Research conducts independent research projects. These studies are investigator initiated and done nearly entirely “in-house”. The research projects are presented annually at the Consortium of Multiple Sclerosis Centers Annual Meeting.
ACAPELLA: Real World Experience with Ocrelizumab: An Observational Study Evaluating Safety in Patients with Relapsing and Progressive Multiple Sclerosis
We sought to compare the frequency of adverse events (AEs) in our population of patients on Ocrevus with the clinical trial population (CTP), and to determine if AEs were more frequent in subjects with age and/or EDSS outside the inclusion criteria of the Phase III trials. This data set reflects results at one year.
Characterizing the Natalizumab “Wearing Off” Effect
The objective of the study was to characterize the prevalence and clinical features of the natalizumab Wearing Off Effect in our patient population.
To Pee or Not To Pee? The Utility of Bladder Scans in Multiple Sclerosis
The objective of the project was to evaluate the frequency of asymptomatic urinary retention and UTIs to assess the utility of PVR measurement in the office setting and to examine the correlation of urinary symptoms with the presence of spinal cord lesions.
Understanding Concepts Important to Natalizumab Patients: A Qualitative Interview Study
The objective of the project was to understand concepts that are the most meaningful to MS patients treated with natalizumab and how patients weigh the benefits/risks of treatment.